✦ LIBER ✦
A phase II randomized study comparing navelbine and capecitabine (Navcap) followed either by Navcap or by weekly docetaxel in the first-line treatment of HER-2/neu negative metastatic breast cancer
✍ Scribed by M. Ghosn; P. Aftimos; F. S. Farhat; J. G. Kattan; C. Hanna; N. Haddad; F. Nasr; G. Chahine
- Publisher
- Springer US
- Year
- 2010
- Tongue
- English
- Weight
- 447 KB
- Volume
- 28
- Category
- Article
- ISSN
- 1357-0560
No coin nor oath required. For personal study only.